PPP2R1Aprotein phosphatase 2 scaffold subunit Aalpha
Autism Reports / Total Reports
6 / 7Rare Variants / Common Variants
25 / 0Aliases
-Associated Syndromes
-Chromosome Band
19q13.41Associated Disorders
-Relevance to Autism
Missense variants in the PPP2R1A gene have been identified in ASD probands from the Autism Sequencing Consortium and, more recently, from a cohort of 75 Turkish patients diagnosed with ASD (Satterstrom et al., 2020; Marques et al., 2022; Fu et al., 2022; Kayhan et al., 2026), while de novo coding-synonymous variants in this gene were previously reported in ASD probands from the MSSNG cohort (Yuen et al., 2017). Lenaerts et al., 2021 described 30 individuals with 16 different PPP2R1A variants presenting with a variable neurodevelopmental disorder characterized by developmental delay with language delay, hypotonia, behavioral problems (including ASD or autistic features in 6 individuals), dysmorphic features, joint hypermobility, and hypoplasia/agenesis of the corpus callosum. Subsequent functional assessment of a subset of disease-associated variants of Lenarets et al., 2021 demonstrated altered PP2A B-type subunit binding, altered C subunit binding, and/or impaired overall PP2A activity, while the ASD-associated p.Ser152Phe variant was shown to cause a reduction in dendritic spine number following expression in hippocampal neurons.
Molecular Function
This gene encodes a constant regulatory subunit of protein phosphatase 2. Protein phosphatase 2 is one of the four major Ser/Thr phosphatases, and it is implicated in the negative control of cell growth and division. It consists of a common heteromeric core enzyme, which is composed of a catalytic subunit and a constant regulatory subunit, that associates with a variety of regulatory subunits. The constant regulatory subunit A serves as a scaffolding molecule to coordinate the assembly of the catalytic subunit and a variable regulatory B subunit. This gene encodes an alpha isoform of the constant regulatory subunit A. Heterozygous variants in this gene are responsible for Houge-Janssens syndrome 2 (OMIM 616362).
External Links
SFARI Genomic Platforms
Reports related to PPP2R1A (7 Reports)
| # | Type | Title | Author, Year | Autism Report | Associated Disorders |
|---|---|---|---|---|---|
| 1 | Support | Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder | C Yuen RK et al. (2017) | Yes | - |
| 2 | Support | Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism | Satterstrom FK et al. (2020) | Yes | - |
| 3 | Support | - | Lisa Lenaerts et al. (2021) | No | ASD, ADHD, epilepsy/seizures |
| 4 | Support | - | Ana Rita Marques et al. (2022) | Yes | - |
| 5 | Support | - | Fu JM et al. (2022) | Yes | - |
| 6 | Support | - | Giovanni Spirito et al. (2026) | Yes | - |
| 7 | Primary | - | Gülsüm Kayhan et al. (2026) | Yes | - |
Rare Variants (25)
| Status | Allele Change | Residue Change | Variant Type | Inheritance Pattern | Parental Transmission | Family Type | PubMed ID | Author, Year |
|---|---|---|---|---|---|---|---|---|
| c.572A>G | p.Glu191Gly | missense_variant | De novo | - | - | 35982160 | Fu JM et al. (2022) | |
| c.96C>G | p.Ile32Met | missense_variant | De novo | - | - | 33106617 | Lisa Lenaerts et al. (2021) | |
| c.421T>A | p.Phe141Ile | missense_variant | De novo | - | - | 33106617 | Lisa Lenaerts et al. (2021) | |
| c.455C>T | p.Ser152Phe | missense_variant | De novo | - | - | 33106617 | Lisa Lenaerts et al. (2021) | |
| c.532A>T | p.Thr178Ser | missense_variant | De novo | - | - | 33106617 | Lisa Lenaerts et al. (2021) | |
| c.533C>A | p.Thr178Asn | missense_variant | De novo | - | - | 33106617 | Lisa Lenaerts et al. (2021) | |
| c.536C>T | p.Pro179Leu | missense_variant | De novo | - | - | 33106617 | Lisa Lenaerts et al. (2021) | |
| c.538A>G | p.Met180Val | missense_variant | De novo | - | - | 33106617 | Lisa Lenaerts et al. (2021) | |
| c.538A>G | p.Met180Val | missense_variant | Unknown | - | - | 33106617 | Lisa Lenaerts et al. (2021) | |
| c.539T>A | p.Met180Lys | missense_variant | De novo | - | - | 33106617 | Lisa Lenaerts et al. (2021) | |
| c.539T>C | p.Met180Thr | missense_variant | De novo | - | - | 33106617 | Lisa Lenaerts et al. (2021) | |
| c.539T>G | p.Met180Arg | missense_variant | De novo | - | - | 33106617 | Lisa Lenaerts et al. (2021) | |
| c.544C>T | p.Arg182Trp | missense_variant | De novo | - | - | 33106617 | Lisa Lenaerts et al. (2021) | |
| c.547C>T | p.Arg183Trp | missense_variant | De novo | - | - | 33106617 | Lisa Lenaerts et al. (2021) | |
| c.656C>T | p.Ser219Leu | missense_variant | De novo | - | - | 33106617 | Lisa Lenaerts et al. (2021) | |
| c.658G>A | p.Val220Met | missense_variant | De novo | - | - | 33106617 | Lisa Lenaerts et al. (2021) | |
| c.772C>A | p.Arg258Ser | missense_variant | De novo | - | - | 33106617 | Lisa Lenaerts et al. (2021) | |
| c.773G>A | p.Arg258His | missense_variant | De novo | - | - | 33106617 | Lisa Lenaerts et al. (2021) | |
| c.659T>G | p.Val220Gly | missense_variant | De novo | - | - | 31981491 | Satterstrom FK et al. (2020) | |
| c.661C>T | p.Arg221Trp | missense_variant | Unknown | - | - | 35327467 | Ana Rita Marques et al. (2022) | |
| c.33C>T | p.Tyr11= | synonymous_variant | De novo | - | Multiplex | 28263302 | C Yuen RK et al. (2017) | |
| c.1525T>C | p.Ser509Pro | missense_variant | Unknown | - | - | 35327467 | Ana Rita Marques et al. (2022) | |
| c.1356G>C | p.Val452= | synonymous_variant | De novo | - | Simplex | 28263302 | C Yuen RK et al. (2017) | |
| c.740C>G | p.Thr247Ser | missense_variant | Unknown | - | - | 41751633 | Gülsüm Kayhan et al. (2026) | |
| c.1375C>T | p.Arg459Cys | missense_variant | De novo | - | Simplex | 41629344 | Giovanni Spirito et al. (2026) |
Common Variants
No common variants reported.
SFARI Gene score
Suggestive Evidence

criteria met
See SFARI Gene'scoring criteriaThe literature is replete with relatively small studies of candidate genes, using either common or rare variant approaches, which do not reach the criteria set out for categories 1 and 2. Genes that had two such lines of supporting evidence were placed in category 3, and those with one line of evidence were placed in category 4. Some additional lines of "accessory evidence" (indicated as "acc" in the score cards) could also boost a gene from category 4 to 3.
4/1/2026
Initial score established: 3
Krishnan Probability Score
Score 0.57091362648016
Ranking 852/25841 scored genes
[Show Scoring Methodology]
ExAC Score
Score 0.71960375288992
Ranking 4380/18225 scored genes
[Show Scoring Methodology]
Sanders TADA Score
Score 0.93437081484241
Ranking 12548/18665 scored genes
[Show Scoring Methodology]
Zhang D Score
Score 0.26955230194313
Ranking 3200/20870 scored genes
[Show Scoring Methodology]